News Releases

The collaboration aims to identify and develop accessible, minimally invasive blood-based biomarkers specific for tau pathology in the brain. These tools have the potential to be used to...

Beckman Coulter Diagnostics, a clinical diagnostics leader, today announced that the DxI 9000 Immunoassay Analyzer* was honored during Premier, Inc.'s annual supplier Innovation Celebration at its...

Ideale sia per laboratori spoke che piccoli, il nuovo analizzatore DxC 500i offre flessibilità, scalabilità e standardizzazione dei dati con un ampio menu di dosaggi di chimica clinica e...

Idéal pour les laboratoires périphériques ou indépendants, le nouvel analyseur DxC 500i offre une flexibilité, une évolutivité et une commutabilité des données grâce à un menu étendu...

Ideal para laboratorios satélites e independientes, el nuevo analizador DxC 500i ofrece flexibilidad, escalabilidad e intercambiabilidad de datos con un extenso menú de ensayos de química...

Das neue Analysensystem DxC 500i ist perfekt für Satelliten- und unabhängige Labore geeignet, da es Flexibilität, Skalierbarkeit und Datenaustausch bietet und gleichzeitig über ein umfassendes...

Ideally Suited for Satellite and Independent Labs, the new DxC 500i Analyzer Offers Flexibility, Scalability and Data Commutability with Extensive Chemistry and Immunoassay Assay Menu The New DxC...

New Access NT-proBNP Assay Detects Heart Failure Biomarker in Less than 11 Minutes Patient Results Evaluated Within Context of Clinically Relevant Age-Based Cutoffs, Disease Comorbidity Data and...

Beckman Coulter Now an Authorized Distributor of MeMed Key Immunoassay System and MeMed BV Assay Progress Continues on Original Collaboration to Develop a MeMed BV-Based Assay for use on Beckman...

Barcelona, 16 de abril de 2024 — A Beckman Coulter Diagnostics, uma das líderes mundiais em diagnósticos clínicos, anunciou hoje, antes do Congresso Europeu de Microbiologia Clínica e...